Z Squared Inc. (ZSQR) Stock Price & Analysis
Z Squared Inc. (ZSQR) rose 2.48% to USD 10.33 as of June 10, 2026 at 09:30 UTC, according to Nexqual real-time market data.
ZSQR last closed at USD 10.08; the session ranged USD 9.88–10.85 on volume of 261,197 shares. Market capitalization is $531.29M, with a 52-week range of USD 6.8–21.41 (NGM). Source: Nexqual, June 10, 2026 at 09:30 UTC.
Key Statistics (as of June 10, 2026 at 09:30 UTC)
| Price | USD 10.33 |
|---|---|
| Change | ▲ 2.48% (up) |
| Previous Close | USD 10.08 |
| Open | USD 10.01 |
| Day Range | USD 9.88 – 10.85 |
| 52-Week Range | USD 6.8 – 21.41 |
| Volume | 261,197 shares |
| Market Cap | $531.29M |
| Exchange | NGM |
Technical Analysis (ZSQR)
Nexqual's technical model rates ZSQR "SELL" based on 1 bullish and 4 bearish signals across 123 daily candles, as of June 10, 2026 at 09:30 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 42.86 (neutral) |
| vs SMA50 | Below (USD 12.03) |
| MACD | -0.57 (negative) |
Analyst Ratings (ZSQR)
Wall Street analysts rate ZSQR "None", per Nexqual as of June 10, 2026 at 09:30 UTC.
| Consensus Rating | None |
|---|
Earnings (ZSQR)
Source: Nexqual, June 10, 2026 at 09:30 UTC.
Financials & Fundamentals (ZSQR)
| Gross Margin | +0.00% |
|---|---|
| Operating Margin | +0.00% |
| Profit Margin | +0.00% |
| ROE | -464.73% |
| Current Ratio | 0.23 |
| Free Cash Flow | $-1.76M |
Source: Nexqual, June 10, 2026 at 09:30 UTC.
Financial Health Score (ZSQR)
Nexqual rates Z Squared Inc.'s overall financial health "Weak" across five dimensions, as of June 10, 2026 at 09:30 UTC.
| Growth | Mixed — No data |
|---|---|
| Profitability | Weak — Gross margin 0%, operating 0% |
| Balance Sheet | Mixed — No data |
| Cash Flow | Weak — Operating cash flow -$7M |
| Efficiency | Critical — ROE -465%, ROA -93.2% |
Ownership (ZSQR)
| Insider Ownership | +1.65% |
|---|---|
| Institutional Ownership | +1.18% |
| Shares Outstanding | 51.43M |
| Float | 3.36M |
Source: Nexqual, June 10, 2026 at 09:30 UTC.
Leadership (ZSQR)
Z Squared Inc. is led by Brian Cogley (age 39), Chief Financial Officer, per Nexqual as of June 10, 2026 at 09:30 UTC.
| Chief Financial Officer | Brian Cogley (age 39) |
|---|---|
| Chief Marketing Officer | Ryan Schadel (age 46) |
Major Backers & Investors (ZSQR)
Notable institutional backers of Z Squared Inc. include Meteora Capital, LLC, according to Nexqual as of June 10, 2026 at 09:30 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Meteora Capital, LLC | 0.22% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 1.3% |
Source: Nexqual, June 10, 2026 at 09:30 UTC.
From Z Squared Inc.'s Latest SEC 10-K Filing (filed 2026-03-19)
Key Strengths & Strategy (as disclosed to the SEC)
- Z Squared Inc. an integrated computing infrastructure company, operates advanced computing equipment distributed across North Carolina, South Carolina, and Iowa.
- The company manages and optimizes a fleet of specialized computing hardware, supported by dynamic power management strategies, real time analytics dashboards, and a comprehensive in house repair and lifecycle management program designed to maximize hardware efficiency and reduce capital waste.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ZVSA | ZyVersa Therapeutics, Inc. | USD 0.17 | ▼ 12.55% |
| MGRX | Mangoceuticals, Inc. | USD 0.34 | ▼ 4.48% |
| CDIO | Cardio Diagnostics Holdings Inc | USD 1.94 | ▼ 1.02% |
| DRMA | Dermata Therapeutics, Inc. | USD 1.2 | ▲ 1.69% |
| AIMD | Ainos, Inc. | USD 2.04 | ▲ 4.62% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 09:30 UTC. This page is informational and not investment advice.